Correct. A clinical trial is just that. Designed to maximise collectable data a human clinical trial helps to establish efficacy and toxicity outcomes without lethal effect. Variation of dosage to achieve optimum outcome is normal. The optimum adaptive dosage response achievable is then plotted to produce a design that can hopefully then be commercially replicated. My opinion only of course!
Ann: Imugene to present at 2024 Cholangiocarcinoma Conference, page-189
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.0¢ |
Change
-0.001(1.41%) |
Mkt cap ! $512.3M | |||
| Open | High | Low | Value | Volume |
| 7.0¢ | 7.1¢ | 6.8¢ | $922.0K | 13.28M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 702419 | 7.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.1¢ | 1365317 | 9 |
View Market Depth
| Last trade - 16.10pm 24/05/2024 (20 minute delay) ? |
|
|||||
|
Last
7.0¢ |
Change
-0.001 ( 1.69 %) |
||||
| Open | High | Low | Volume | ||
| 7.0¢ | 7.1¢ | 6.8¢ | 5455105 | ||
| Last updated 15.59pm 24/05/2024 ? | |||||
| IMU (ASX) Chart |